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Abstract
 
The function of the intraepithelial lymphocyte (IEL) network of T cell receptor (TCR) 
 
  
 
 
 
(V
 
 
 
5
 
 
 
) dendritic epidermal T cells (DETC) was evaluated by examining several mouse strains
 
genetically deficient in 
 
  
 
 T cells (
 
 
 
 
 
/
 
  
 
mice), and in 
 
 
 
 
 
/
 
  
 
mice reconstituted with DETC or
with different 
 
  
 
 cell subpopulations. NOD.
 
 
 
 
 
/
 
  
 
and FVB.
 
 
 
 
 
/
 
  
 
mice spontaneously developed
localized, chronic dermatitis, whereas interestingly, the commonly used C57BL/6.
 
 
 
 
 
/
 
  
 
strain
did not. Genetic analyses indicated a single autosomal recessive gene controlled the dermatitis
susceptibility of NOD.
 
 
 
 
 
/
 
  
 
mice. Furthermore, allergic and irritant contact dermatitis reactions
were exaggerated in FVB.
 
 
 
 
 
/
 
 
 
, but not in C57BL/6.
 
 
 
 
 
/
 
  
 
mice. Neither spontaneous nor aug-
mented irritant dermatitis was observed in FVB.
 
 
 
 
 
/
 
  
 
 
 
 
 
/
 
  
 
mice lacking all T cells, indicating
that 
 
  
 
 T cell–mediated inflammation is the target for 
 
  
 
-mediated down-regulation. Reconsti-
 
tution studies demonstrated that both spontaneous and augmented irritant dermatitis in FVB.
 
 
 
 
 
/
 
 
 
mice were down-regulated by V
 
 
 
5
 
 
 
 DETC, but not by epidermal T cells expressing other 
 
  
 
TCRs. This study demonstrates that functional impairment at an epithelial interface can be spe-
cifically attributed to absence of the local TCR-
 
  
 
 
 
 IEL subset and suggests that systemic in-
flammatory reactions may more generally be subject to substantial regulation by local IELs.
Key words: dermatitis • TCR 
 
  
 
 • mast cells • NOD • FVB
 
Introduction
 
Although adaptive immune responses to pathogens are
triggered by exquisitely specific antigen receptors on re-
sponding, systemic T and B cells, the resulting effector
mechanisms that eliminate the pathogen are typically not
 
antigen specific, and can result in considerable damage to
host tissues in which the pathogen and/or its products occur.
Furthermore, adaptive immune responses are also frequently
provoked by relatively innocuous environmental antigens
that gain access to the body at epithelial interfaces with the
environment, e.g., the skin, the genitourinary and the gas-
trointestinal tracts. Such allergic and inflammatory re-
sponses are a major cause of human disease.
One mechanism for controlling adaptive immune re-
 
sponses to such antigens is the induction of regulatory 
 
  
 
 
 
T cells that enter the systemic circulation, and upon reen-
countering antigen, secrete cytokines (e.g., IL-10) that
down-regulate potentially tissue-damaging inflammatory
responses initiated by antigen-specific effector T cells (1–7).
Additionally, immunoregulatory functions have been
 
demonstrated for systemic TCR-
 
  
 
 
 
 cells that, in many
mammals including mice and humans, constitute a minor
population of circulating T cells (8–10). In sum, the sys-
temic circulation harbors subsets of cells that can provoke
inflammation, and those that can suppress it.
In addition to recirculating T cells, some T cells are con-
stitutively resident within epithelia. By virtue of the large
surface area of epithelia, such intraepithelial lymphocytes
 
(IELs)
 
*
 
, including those in the human gut, may be among
the most abundant T cell subsets. One conspicuous IEL
repertoire is composed of dendritic epidermal T cells
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V
 
 
 
5
 
 
 
 DETC Down-Regulate Cutaneous Inflammation
 
(DETC) that populate the skin of all normal mice. Most
DETC express an identical V
 
 
 
5/V
 
 
 
1 TCR (11–13).
The same V
 
 
 
5/V
 
 
 
1 TCR is expressed early in gestation
(
 
 
 
E14-E17) on a small fraction of fetal thymocytes that
can reconstitute the skin of DETC-deficient (e.g., nude)
mouse recipients (12, 14, 15). Furthermore, V
 
 
 
5/V
 
 
 
1
 
 
 
 T
cells in adult mice are apparently restricted to the skin, as
such cells are not present in lymph nodes, spleen and
blood, or in other epithelial sites (e.g., gastrointestinal tract,
genitourinary tract, lungs) that are by contrast populated by
their own distinctive subsets of 
 
  
 
 
 
 IELs (12, 16–18).
IELs have been variously proposed to interact with epi-
thelial cells, activated T cells, and antigen presenting cells
(19–22). A very recent study has provided evidence in
three different mouse models of skin cancer that 
 
  
 
 cells,
including DETCs can function as antiepithelial tumor ef-
fector cells (23). This complements other studies demon-
strating that human intestinal 
 
  
 
 
 
 IELs will kill human
bowel carcinomas and other intestinal epithelial cell lines
(24, 25), and that there is enhanced formation of chemi-
cally induced colorectal carcinomas in 
 
 
 
 
 
/
 
  
 
mice (26). In
addition to protecting epithelial tissues from disruption by
transformed or infected epithelial cells, it has been hypoth-
esized that 
 
  
 
 
 
 IELs might likewise protect epithelial tis-
sues from damage or disruption by systemic, proinflamma-
tory infiltrates. Indeed, data from a variety of studies are
consistent with the possibility that resident 
 
  
 
 
 
 IELs in the
skin or the gut locally down-regulate inflammatory re-
sponses to allergens or pathogens initiated by conventional
 
  
 
 T cells (27–32). However, in none of those earlier
studies did the experimental design critically test the hy-
pothesis that the subset of 
 
  
 
 
 
 cells normally present in a
particular site (e.g., V
 
 
 
5
 
 
 
 DETC in the skin) may be a crit-
ical, nonredundant regulator of a spectrum of physiological
inflammatory reactions occurring within its immediate
confines, i.e., that purified V
 
 
 
5
 
 
 
 DETC down-regulate
different types of cutaneous inflammatory reactions, while
other 
 
  
 
 
 
 cells do not.
To test this hypothesis, we have used several different ge-
netic strains of 
 
 
 
–/–
 
 mice to examine the physiological con-
sequences of cutaneous IEL (DETC) deficiency. The results
demonstrate that some, but not other strains of 
 
 
 
 
 
/
 
  
 
mice
spontaneously develop localized chronic dermatitis. The
pathology is driven by 
 
  
 
 T cells, since mice lacking both
 
  
 
 T cells and 
 
  
 
 cells are asymptomatic. Consistent with
this, TCR-
 
 
 
 
 
/
 
 
 
 mice displaying spontaneous dermatitis also
show augmented allergic and irritant contact dermatitis re-
actions. Adoptive transfer experiments in which susceptible
FVB.
 
 
 
 
 
/
 
  
 
mice received either V
 
 
 
5
 
 
 
 cells (that selectively
reconstitute DETC) or other subpopulations of 
 
  
 
 cells,
showed that V
 
 
 
5
 
 
 
 DETC are necessary and sufficient to
down-regulate both spontaneous and irritant contact der-
matitis. In sum, these studies demonstrate that a local 
 
  
 
IEL subset can contribute a general and nonredundant role
in regulating the inflammatory infiltration of tissue pro-
voked by conventional 
 
  
 
 T cells. In addition, because of
its strain-dependence, and because it shares several charac-
teristics of atopic dermatitis, a common, but incompletely
understood human skin disease, the experimental approach
described may provide a novel animal model for studying
the genetic control of inflammatory pathology.
 
Materials and Methods
 
Animals.
 
TCR.
 
 
 
 
 
/
 
 
 
, and TCR.
 
 
 
 
 
/
 
  
 
C57BL/6 mice (Jack-
son ImmunoResearch Laboratories) were backcrossed to FVB
(Taconic) and nonobese diabetic (NOD/LtJ; Jackson Immu-
noResearch Laboratories) mice, 11 and 14 generations, respec-
tively. FVB.
 
 
 
 
 
/
 
 
 
 
 
 
 
/
 
 
 
 mice were produced by first crossing
FVB.
 
 
 
 
 
/
 
  
 
(N11) with FVB.
 
 
 
 
 
/  (N11) mice to obtain double-
heterozygotes, and then intercrossing these animals to obtain the
double-knockouts. For genetic studies, using both sexes in each
strain, NOD.  /  mice were mated with C57BL/6.  /  mice to
produce both (NOD    C57BL/6)F1.  /  and (C57BL/6  
NOD)F1. –/– offspring. F1.  /  mice were subsequently inter-
crossed to produce F2. –/– offspring, and were backcrossed to
NOD.  /  mice (again using both sexes) to produce (F1   
NOD)BC.  /  and (NOD   F 1)BC. –/– animals. Mice were
kept in filter-topped cages with sterilized food and water, and au-
toclaved corncob bedding, changed at least once weekly. Repeat
testing of these mice failed to identify known bacterial pathogens,
mites, or pinworms on the skin.
Contact Dermatitis. To induce allergic contact dermatitis
(ACD), mice were sensitized on day 0 by epicutaneous applica-
tion to razor-shaved abdominal skin of 25  l of 0.5% DNFB in a
mixture of acetone:olive oil (4:1). On day 5, after measuring
baseline ear thickness with an engineer’s micrometer, mice were
challenged by applying 10  l of 0.2% DNFB in acetone:olive oil
to each side of each ear. Ears were remeasured 24 h after chal-
lenge; data are expressed as the ear swelling response above base-
line (i.e., ear thickness 24 h after challenge minus ear thickness
immediately before challenge)  1 SE of the mean (SE).
For adoptive transfer of ACD reactivity, groups of immune
lymph node cell donor mice (either FVB or FVB.  / ) were sen-
sitized by application of 25  l of 0.5% DNFB to the shaved abdo-
men and 3  l to each paw, the tip of the jaw, and each side of
each ear. 5 d later, single cell suspensions were prepared from the
draining lymph nodes (cervical, axillary, inguinal, and femoral) of
each group of donors. Groups of normal adult FVB recipient
mice were injected intravenously with graded numbers of
DNFB-immune lymph node cells; 2 h later, after measuring base-
line each thickness, recipient ears were challenged with 0.2%
DNFB. Ears were remeasured 24 h later, and the ear swelling re-
sponse above baseline calculated.
For irritant contact dermatitis (ICD) assays, after measuring
baseline ear thickness, 20 nmol tetradecanoylphorbol acetate
(TPA) (in 10  l acetone) were applied to each side of each ear of
adult mice. Ears were remeasured 24 h after challenge (and in in-
dicated experiments, again at 6 d after challenge), and mean ear
swelling responses above baseline calculated as above. In one
study (indicated in the text and legend to Fig. 5 B) TPA was re-
applied to the ears weekly for a total of three applications.
Flow Cytometry. To sort fetal thymocytes, a single cell sus-
pension was prepared in Hank’s balanced salt solution from thymi
obtained from E17 FVB fetuses obtained after timed matings.
Red blood cells and dead cells were removed by Lympholyte M
(Accurate) density gradient centrifugation. Thymocytes were
then blocked with normal hamster IgG and anti-FcR (2.4G2; BD
PharMingen), stained with anti-V 5 (FITC-F536; BD PharMin-
gen), or isotype-matched control, and sorted into V 5  and V 5–857 Girardi et al.
populations on a FACSVantage™ (Becton Dickinson) using
CellQUEST™ software.
To analyze epidermal T cell populations, separate epidermal
cell suspensions were prepared as described from both ears of in-
dividual animals (13). After overnight culture to allow reexpres-
sion of trypsin-sensitive epitopes, epidermal cells were blocked
with normal hamster IgG plus anti-FcR (2.4G2), and stained
with hamster mAbs to CD3 (FITC-2C11; BD PharMingen),
TCR-  (Biotin-GL3 or FITC-GL3; BD PharMingen) and V 5
(Biotin-F536; BD PharMingen). Biotinylated antibodies were vi-
sualized with phycoerythrin-streptavidin. Isotype-matched con-
trol antibodies were used at the same concentrations as test anti-
bodies. Analysis was performed with a FACScan™ (Becton
Dickinson) with electronic gates set on live cells by a combina-
tion of forward and side light scatter and propidium iodide exclu-
sion. A minimum of 104 live events was collected per sample and
data were analyzed with CellQUEST™ software.
To analyze adult lymph node cells, aliquots from a single cell
suspension of PLN (axillary and inguinal) cells from 8-wk-old
FVB.  /  donors were blocked with normal hamster IgG and
anti-FcR, and then stained with either FITC-F536, FITC-GL3,
or isotype-matched control antibody. FACScan™ analysis as de-
scribed immediately above documented that the suspension con-
tained  15%     (GL3 ) T cells, but no detectable V 5  cells.
Statistical Analysis. Comparisons between datasets were made
using a standard Student’s two-tailed t test (33), unless otherwise
specified. Chi-square analysis (34) was used to compare the phe-
notypic presence of ear crusting after irritant challenge between
groups of mice, and to compare baseline ear thickness in different
groups of mice (e.g., males versus females) using as a cutoff  5
SD above the average means for “resistant” B6.  /  and F1.  / 
mice. In all cases, P   0.05 was considered significant.
Results
Strain-dependent Development of Spontaneous, Localized,
Chronic Dermatitis in   /  Mice.   /  mice on C57BL/6,
FVB, or NOD backgrounds were examined for evidence of
a cutaneous phenotype. Unmanipulated NOD.  /  mice
developed a spontaneous cutaneous inflammation of the
ears, manifested by erythema, edema, and pruritus, evident
by 5–6 wk of age and becoming more obvious with age.
This was not observed in any normal NOD controls (Fig. 1
A and B). In contrast to the normal histology of NOD ear
skin, NOD.  /  ear skin showed histopathologic features
typical of chronic dermatitis; a thickened epidermis with
mild intercellular edema, scattered intraepidermal mononu-
clear inflammatory cells, and a thickened dermis with dilated
blood vessels, mononuclear inflammatory cells, occasional
eosinophils, and strikingly increased numbers of mast cells
(Fig. 1 C and D). Micrometer measurements confirmed
markedly increased baseline ear thickness (Fig. 1 E). Histo-
pathologic evaluation of kidney, liver, spleen, small and
large intestine, lung, and abdominal and back skin revealed
no evidence of inflammation and no obvious differences be-
tween 12-wk-old NOD.  /  mice and NOD controls.
Highly significant, but less dramatic differences in base-
line ear thickness also developed spontaneously in FVB.  / 
mice relative to age-matched FVB controls (Fig. 1 E); this
was paralleled by qualitatively similar, albeit less intense,
histologic differences as described for NOD.  /  mice (data
not shown). Such changes developed in FVB.  /  mice in
the absence of overt clinical signs of spontaneous dermatitis,
i.e., pruritus or erythema. In marked contrast, C57BL/
6.  /  mice observed over a 6-mo period developed nei-
ther clinical nor histologic evidence of spontaneous derma-
titis nor increased baseline ear thickness relative to age-
matched C57BL/6 controls, thereby confirming an earlier
study which reported no obvious phenotype in unmanipu-
lated C57BL/6.  /  mice (30). Thus, the spontaneous de-
velopment of localized chronic dermatitis in   /  mice is
strikingly strain dependent.
To understand better the genetics governing the suscep-
tibility to spontaneous dermatitis, NOD.  /  mice and
C57BL/6.  /  mice were mated to produce F1.  /  off-
spring. F1.  /  mice were subsequently intercrossed to
produce F2.  /  offspring, while others were backcrossed
to NOD.  /  mice to produce (F1   NOD) and (NOD  
F1) BC.  /  animals. Ear-thickness, as a manifestation of
spontaneous dermatitis, was then examined in large num-
bers of these mice (Fig. 2). The data have been segregated
by sex, and show that baseline ear thickness in males tends
to be higher than age-matched female counterparts (an ex-
pected finding given their larger size). Despite some vari-
ance observed in NOD.  /  mice, the mean ear thickness
at 8–12 wk of age was markedly greater than age- and sex-
matched C57B/6.  /  mice housed under identical condi-
tions (Student’s t test, unequal variance: P   10 25), con-
firming the strain-dependent differences originally seen in
smaller groups of animals (Fig. 1 E). F1.  /  progeny dis-
played no clinical signs of spontaneous dermatitis, and their
baseline ear thickness was indistinguishable from that seen
in age- and sex-matched C57BL/6.  /  mice. These re-
sults indicate that either the NOD background contributes
recessive alleles that permit augmented cutaneous inflam-
mation in the absence of    cells, and/or the C57BL/6
background contributes dominant alleles that overcome the
effects of    cell deficiency.
Such an inheritance pattern is consistent with both the
F2 and BC data shown in Fig. 2. To identify susceptible
(“NOD-like”) mice, increased baseline ear thickness was
defined as  5 SDs above the average means for “resistant”
B6.  /  and F1.  /  mice; i.e., F2 and BC females with an
ear thickness of  14.0, and F2 and BC males with an ear
thickness  15.5 were classified as susceptible. Using these
criteria, 24.5% (41/167) of the F2 mice could be classified
as NOD-like, while 42% (99/235) of the BC mice have
the NOD-like phenotype. The incidence of spontaneous
dermatitis of 25% in F2 mice and 42% in BC animals is
consistent with the possibility that a single autosomal reces-
sive gene is primarily responsible for the susceptibility of
NOD.  /  mice. In such a case, the expected frequency of
the phenotype in the F2 population is 25% and in the back-
cross population is 50%. Preliminary results examining F1,
F2, and BC offspring from mating of C57BL/6.  /  and
FVB.  /  mice are likewise consistent with a single autoso-
mal recessive gene controlling the susceptibility to sponta-
neous dermatitis in FVB.  /  mice (data not shown).858 V 5  DETC Down-Regulate Cutaneous Inflammation
Further analysis of crosses between NOD.  /  and
C57BL6.  /  mice revealed that among F2.  /  mice,
32% (26/80) of females and 17% (15/87) of males were
NOD-like. Among BC.  /  mice, 48% (55/114) of fe-
males and 36% (44/121) of males were NOD-like. These
differences between the male and female incidences of the
susceptible phenotype were not statistically significant.
Likewise, the frequency of phenotypically susceptible mice
was similar in groups of BC animals segregated according
to the sex of the NOD parent (data not shown). In sum,
there was no statistically significant evidence for sex-linked
genes affecting the development of spontaneous dermatitis.
Strain-dependent Increases in Allergic and Irritant Contact
Dermatitis Reactions in   /  Mice. FVB.  /  and C57BL/
6.  /  mice, as well as their respective TCR-   controls,
were next compared for their ACD responses to the aller-
gen 2,4-dinitrofluorobenzene (DNFB). 24 h after DNFB
challenge, sensitized FVB.  /  mice showed strikingly aug-
mented ear swelling (measured as increase above baseline
thickness) compared with sensitized, and challenged FVB
mice. In contrast, responses of C57BL/6.  /  mice were
indistinguishable from C57BL/6 controls (Fig. 3 A). Such
enhanced ACD reactions in FVB.  /  mice were not re-
stricted to DNFB; ear swelling in mice sensitized and chal-
lenged with the chemically unrelated allergen dimethyl-
benzanthracene (DMBA) was also significantly greater than
in FVB controls (data not shown).
ACD involves two distinct phases (35): during initiation,
naive T cells in draining lymph nodes undergo antigen-
driven clonal expansion and differentiate into effector cells;
during elicitation, after reexposure to allergen, small num-
bers of antigen-specific effector T cells accumulate at sites of
Figure 1. Spontaneous dermatitis in the ears of unmanipulated   /  mice is strain depen-
dent. (A) 12-wk-old NOD.  /  mice exhibit spontaneous ear erythema, while (B) age-
matched NOD controls mice do not. (C) H&E stained section (original magnification:
200 ) of a 12-wk NOD.  /  ear shows histologic features of chronic dermatitis, including
increased numbers of mast cells (shown in left inset, Giemsa stain, Original magnification:
400 ; and right inset, H&E stain. Original magnification: 400 ). (D) H&E section of unin-
flamed ear of 12-wk-old NOD control mouse. (E) Increased baseline ear thickness of unma-
nipulated 12-wk-old NOD.  /  and FVB.  /  mice compared with age-matched NOD
and FVB controls contrasts with the indistinguishable baseline ear thickness measured in 12-
wk-old C57BL/6.  /  and C57BL/6 control mice (n   12–18 mice per group). Data ex-
pressed as mean  SE.859 Girardi et al.
allergen reapplication where their triggering initiates a proin-
flammatory cascade (including increased vascular permeabil-
ity; influx of other inflammatory cells and associated tissue
swelling; and epidermal cell injury and proliferation). To dis-
tinguish whether    cells regulate ACD initiation and/or
elicitation, draining lymph node cells from DNFB-immu-
nized FVB or FVB.  /  donors were compared for their ca-
pacity to transfer anti-DNFB reactivity to nonsensitized
Figure 2. Spontaneous cutaneous inflam-
mation in crosses of susceptible NOD.  / 
with resistant C57BL/6   /   mice.
NOD.  /  and C57BL/6.  /  mice were
bred to produce F1, F2, and (F1   NOD)
backcross (BC) offspring. Each symbol rep-
resents an individual animal, and data is
shown separately for females (F) and males
(M) of each group. Mean baseline ear thick-
ness  SD is given for each group of animals.
Figure 3. Increased allergic and irritant contact
dermatitis reactions in   /  versus wild-type mice
are dependent on genetic background. (A) ACD
responses 24 h after DNFB challenge of DNFB-
immune control and   /  FVB and C57BL/6 mice
(n   10–20 mice per group; data expressed as mean
 SE). Ear swelling above baseline in FVB. –/–
mice was more than twice that in FVB control mice
(P    0.0001), while responses of C57BL/6.  / 
and control mice were indistinguishable. N.S., no
significant difference. (B) Irritant contact dermatitis
responses 24 h after TPA challenge of FVB and
C57BL6   /  and control mice. n   10–15 mice
per group; data expressed as mean  SE. Ear swell-
ing above baseline of FVB.  /  mice was nearly
twice that of FVB mice (P   0.0001), while equiv-
alent responses were seen in C57BL/6.  /  and
C57BL/6 mice. (C) Adoptive transfer of graded
numbers of lymph node cells from DNFB-sensi-
tized FVB.  /  or FVB donors to naive adult FVB
recipients results in equivalent ear swelling re-
sponses 24 h after DNFB challenge.860 V 5  DETC Down-Regulate Cutaneous Inflammation
adult FVB recipients. Cell yields from the draining lymph
nodes of each strain were equivalent ( 20   106 cells per
donor), and the dose–responses of cells from normal and   / 
mice were indistinguishable (Fig. 3 C). Thus, during ACD
initiation, similar numbers and/or activities of antigen-spe-
cific effector T cells are generated in   /  and control mice.
Since    cells do not inhibit the initiation phase of ACD re-
actions, their more likely target is the elicitation phase.
Irritant contact dermatitis (ICD) reactions develop with
delayed kinetics and histopathologic changes similar to
ACD reactions. However, unlike ACD, ICD can be elic-
ited in all individuals upon first exposure to sufficient con-
centrations of the irritant. Since ICD reactions do not re-
quire effector T cells specific for the offending chemical,
they have only an elicitation phase. Thus, ICD provides an
additional means by which to test whether    cells regulate
elicitation events. FVB.  /  mice and C57BL/6.  /  mice,
along with counterpart TCR-   controls, were challenged
with TPA, the active agent in the irritant croton oil, and
the resulting ICD reactions compared by measuring the in-
crease in ear thickness above baseline 24 h postchallenge.
Again, irritant reactions to TPA were markedly increased
in FVB.  /  mice (Fig. 3 B), providing further evidence
that    cells down-regulate contact dermatitis elicitation
events. Although the contact dermatitis responses were
quantitated using the conventional measurement of ear
swelling above baseline (i.e., baseline ear thickness has been
subtracted), it is possible that the preexisting low-grade
spontaneous dermatitis of FVB.  /  mice may have con-
tributed to the augmented allergic and irritant responses;
indeed other studies have shown that preexisting dermatitis
predisposes such sites to enhanced irritant and ACD upon
subsequent challenge (36–38).
In contrast to the enhanced ICD reactions to TPA ob-
served in FVB.  /  mice, TPA challenge of C57BL/6.  / 
mice resulted in ear swelling responses indistinguishable
from those measured in C57BL/6 animals (Fig. 3 B), dem-
onstrating that    cell down-regulation of contact dermati-
tis to irritants is also genetically controlled. Collectively, the
failure of TCR-  /  mice on the C57BL/6 background to
exhibit consistent differences from their wild-type counter-
parts with regard to either spontaneous or chemically in-
duced contact dermatitis reactions, suggests that the con-
ventional use of the C57BL/6 background for analysis of
the TCR-  /  phenotype may have substantially underes-
timated the nonredundant roles that can be played by   
cells in vivo (22).
Spontaneous and Augmented Irritant Dermatitis Responses in
  /  Mice Require    T Cells. To investigate whether   
T cells might directly or indirectly be targets of the antiin-
flammatory effects of    cells, FVB mice deficient in both
in    and    T cells (FVB.  /   / , backcrossed 11 gen-
erations onto the FVB background) were compared with
FVB. –/– mice and FVB controls (Fig. 4). Increased baseline
ear thickness (spontaneous dermatitis) was again seen in
FVB.  /  mice; in contrast, the baseline ear thickness of
Figure 4. Increased baseline ear thickness (spontaneous dermatitis) and
augmented irritant contact dermatitis responses to TPA in FVB.  /  mice
are dependent on the presence of    T cells. (A) Baseline ear thickness is
higher in 10-wk-old FVB.  /  mice than in FVB controls; however,
age-matched FVB.  /   /  mice (deficient in both     and     T cells)
exhibit no difference in baseline ear thickness relative to control FVB
mice (n   10 mice per group; data expressed as mean  SE). (B) Irritant
contact reactions of the same mice 24 h after challenge with TPA. As in
Fig. 2 B, irritant reactions (shown as ear swelling above baseline) are sig-
nificantly greater in FVB.  /  mice
than in FVB controls; however, ear
swelling in FVB.  /   /  mice is
not significantly different from that
in FVB controls. (C) 6 d after TPA
challenge, FVB.  /   ears demon-
strate histologic features of subacute
dermatitis, while ears of representa-
tive FVB controls and FVB.  /   / 
mice exhibit equivalent, and much
less striking, evidence of inflamma-
tion (H&E, original magnification:
200 ).861 Girardi et al.
FVB.  /   /  mice was indistinguishable from controls,
clearly indicating that    T cells are required for the devel-
opment of spontaneous inflammation which occurs in the
absence of    cells (Fig. 4 A). Similarly, while augmented
irritant responses after TPA challenge were again seen in
FVB.  /  mice, the irritant response in FVB.  /   /  mice
was not significantly different from that of controls (Fig. 4
B). These data demonstrate that augmented ICD responses
observed in the absence of    cells also depend, at least in
part, on the presence of    T cells. These results seen 24 h
after TPA challenge were confirmed and extended by anal-
ysis of these same groups of mice several days later. 6 d after
TPA challenge, the ears of all FVB.  /  ears demonstrated
histologic features of subacute dermatitis; variable amounts
of scale-crust overlying a thickened epidermis with intraepi-
dermal edema and intraepidermal mononuclear inflamma-
tory cells, and a markedly thickened dermis containing a
prominent infiltrate of mononuclear inflammatory cells and
mast cells (Fig. 4 C). In contrast, ears of representative FVB
and FVB.  /   /  mice exhibited equivalent, and much
less striking, evidence of inflammation. Furthermore, as
shown in Table I, 6 d after TPA challenge, 89% (16/18) of
the ears of FVB.  /  mice showed visible scale-crust forma-
tion (another clinical sign of severe dermatitis), whereas
0/20 ears of control mice, and only 17% (3/18) ears of
  /   /  mice developed scale-crust ( 2 analysis: P   
0.001 for FVB.  /  versus controls; no significant difference
for FVB.  /   /   versus controls). Moreover, in 7/18
FVB.  /  ears, the severity of scale-crust formation was
greater than that seen in any FVB.  /   /  mice. These
findings demonstrate that    T cells are responsible for the
development of the spontaneous dermatitis responses of
FVB.  /  mice, and contribute to their enhanced irritant
responses. In sum, the data suggest that a major function of
   cells in genetically susceptible strains is to down-regulate
local inflammatory responses provoked by    T cells.
V 5  DETCs Are Necessary and Sufficient for Down-Regu-
lation of Dermatitis. A key question was whether selective
reconstitution of  –/– animals with V 5  DETC would re-
store normal regulation of cutaneous inflammation. Prior
studies had shown that the E14–17 fetal thymus contains
V 5  DETC precursors which upon adoptive transfer re-
constitute V 5  DETC in the skin of DETC-deficient
(i.e., nude) recipients (12, 14, 15). Accordingly, one group
of 1–3 d-old FVB.  /  mice was inoculated (intraperito-
neally) with two fetal thymus equivalents (8   104) of flow
cytometry-sorted ( 98% pure) V 5  E17 fetal thymo-
cytes; a second group received 2   106 (two fetal thymus-
equivalents) of sorted V 5– E17 fetal thymocytes; a third
group was left as unreconstituted FVB.  /  controls. 10 wk
later, spontaneous inflammation in these groups and in age-
matched FVB controls was assessed blind by measuring
baseline ear thickness (Fig. 5 A). Immediately thereafter,
cell suspensions prepared by trypsinization of epidermal
sheets from the ears of individual mice were analyzed by
flow cytometry to determine the phenotype(s) of the T
cells present within the epidermis. Fig. 5 B shows the mean
percentage  SE of V 5  (F536 ),     (GL3 ), and    
cells (the number of CD3 , i.e., 2C11 , cells minus the
number of GL3  cells) for each group of animals, while
Fig. 5 C shows flow cytometry contour plots from a repre-
sentative animal from each group.
Baseline ear thickness of FVB.  /  mice reconstituted
with sorted V 5  cells was indistinguishable from that
measured in FVB controls, and significantly less than unre-
constituted FVB.  /  mice (Fig. 5 A). Fig. 5 B and C
show that cell suspensions prepared from the spontane-
ously inflamed ears of FVB.  /  mice were, as expected,
devoid of    cells, but contained significant numbers of
presumably proinflammatory, infiltrating    T cells (i.e.,
CD3     ), while the noninflamed ears of control mice
contained T cells which were overwhelmingly V 5 , with
small, but measurable numbers of V 5      cells and rare
    cells. The    cells isolated from the clinically nonin-
flamed ears of FVB.  /  mice inoculated as newborns with
sorted V 5   fetal thymocytes were exclusively V 5 
DETC and were present in proportions indistinguishable
from control mice. Thus, prototypic V 5  DETC are
clearly sufficient to restore wild-type (antiinflammatory)
function to FVB.  /  skin. The increased baseline ear
thickness measured in recipients of V 5– fetal thymocytes
was similar to that in uninjected FVB.  /  mice (Fig. 5 A).
However, because the ears of mice receiving V 5– fetal
thymocytes were only minimally reconstituted with V 5 
    T cells (0.15 vs. 1.5% present in normal FVB mice;
Fig. 5 C, h versus f), this experimental group did not allow
one to conclude that V 5      cells could not also func-
tion as antiinflammatory cells within the skin, were they to
be present in substantial numbers.
To address this question, an experimental approach was
adopted that built on previous studies showing that the skin
of experimentally manipulated mice can be repopulated by
V 5     cells, including those expressing TCRs expressed
by    cells found in PLNs or spleen (13, 39, 40). There-
fore, selective reconstitution of FVB.  /  mice was again
undertaken, this time including a group of newborn
FVB.  /  mice inoculated with 1.5   106 V 5      cells
Table I. Crusting Response Observed in FVB.  /  Mice 6 d after 
TPA Challenge Is Dependent on the Presence of    T Cells
Crusting indexb
Total with crusting Na Strain 0         
18 FVB.  /  293 4 1 6 c
20 FVB.   20 0 0 0 0c, d
18 FVB.  /   /  15 3 0 0 3d
aN   number of ears.
bCrusting index: 0, no crusting;  , crusting at ear tip;   , crusting of
25–75% of ear;    , crusting of  75% of ear.
cP   0.01, chi-square analysis for presence of crusting in FVB.  / 
versus FVB controls or FVB.  /   / .
dNo significant difference for FVB controls versus FVB.  /   / .862 V 5  DETC Down-Regulate Cutaneous Inflammation
obtained from adult FVB. –/– donor PLNs, as well as a
group again reconstituted with V 5  E17 fetal thymocytes.
10 wk later, after blind measurements of baseline ear thick-
ness (Fig. 6 A), all mice were challenged once a week with
the irritant TPA, and repeat measurements taken 24 h after
the third challenge (Fig. 6 B). Subsequently, epidermal cell
suspensions from the ears of individual mice were again an-
alyzed by flow cytometry for their proportions of     cells,
CD3      (i.e.,   ) cells, and V 5  cells (i.e., prototypic
DETCs) (Fig. 6 C).
Unreconstituted FVB TCR-  /  mice once again ex-
hibited both spontaneous inflammation and augmented
ICD reactions after TPA challenge compared with FVB
mice (Fig. 6 A and B). Fig. 6 C (a and e versus b and f)
shows that even in FVB mice repetitively challenged with
TPA,  90% of epidermal T cells are    cells, the majority
of which are V 5 . In contrast, unreconstituted FVB.  / 
ear epidermis contained no    cells, but was infiltrated
with large numbers of    cells. Since these analyses were
performed after serial TPA challenge, it is likely that some
of these epidermal    cells were nonresident, proinflam-
matory    T cells recruited into the ears as part of the
spontaneous dermatitis in unmanipulated FVB.  /  mice,
while others migrated in as part of the ICD response to
TPA. In this experiment, the proportion of V 5  DETC
in the ears of FVB.  /  mice injected with sorted V 5  fe-
tal thymocytes was only  36% of that seen in normal mice
(Fig. 6 C, g versus f). Nonetheless, such prototypic DETC-
reconstituted FVB.  /  mice displayed baseline ear thick-
ness and ICD responses to TPA indistinguishable from
controls and significantly less than unreconstituted FVB.  / 
mice (Fig. 6 A and B). In contrast, FVB.  /  mice in-
jected at birth with V 5     cells exhibited both spontane-
ous ear inflammation and augmented ICD reactions essen-
tially the same as those measured in unreconstituted
FVB.  /  mice (Fig. 6 A and B). The failure of these V 5 
cells to restore normal function to the skin of FVB.  / 
mice could not on this occasion be explained by their in-
ability to repopulate the skin, since the epidermis of such
animals contained at least as many V 5     cells as were
present in normal FVB mice (Fig. 6 C, h versus f). In sum,
each of two reconstitution studies of genetically deficient
mice have demonstrated that prototypic V 5  DETC
down-regulate    T cell–provoked cutaneous inflamma-
Figure 5. Reconstitution with V 5  E17 fetal thy-
mocytes (DETC precursors) is sufficient to prevent sponta-
neous dermatitis in FVB.  /  mice. (A) Baseline ear thick-
ness of 10-wk-old FVB mice (n   4–5 mice per group;
data expressed as mean  SE): unreconstituted FVB.  / 
mice (positive controls); normal FVB.   mice (negative
controls); FVB.  /  mice inoculated (intraperitoneally) as
1–3 d old neonates either with flow cytometry-purified
(98% pure) V 5  E17 fetal thymocytes (8   104 105 cells),
or with flow cytometry-purified V 5– E17 fetal thy-
mocytes (2   106 cells). (B) Flow cytometric analysis of
epidermal cell suspensions individually prepared from the
ears of these same mice. n   4–5 mice per group. Data is
expressed as the mean percentage ( SE) of epidermal cells
which stained as V 5  DETC (F536  GL3 ; black bars),
as V 5     T cells (F536  GL3 ; white bars), or as    T
cells (CD3  GL3 ; hatched bars). nd, non-detected. (C)
Flow cytometric analyses of epidermal cell suspensions pre-
pared from the ears of a representative from each of the
above four groups of mice. Numbers in lower right-hand
corners of the quadrants of the contour plots indicate per-
centages of live cells within those quadrants.863 Girardi et al.
tion. Moreover, in one experiment where it was possible to
populate the skin with substantial numbers of    cells bear-
ing non-DETC TCRs, such down-regulation of    T
cell–provoked local inflammation was not seen. Together,
these data provide functional evidence for the importance
both of DETC and of the TCR that they express.
Discussion
Previous studies have documented that mice deficient in
all    cells may exhibit defective down-regulation of in-
flammation induced experimentally in various tissues, in-
cluding epithelial interfaces with the external environment:
e.g., localized graft-versus-host disease in the skin (30); par-
asitic infection of the gastrointestinal track (32); and phar-
macologic (41), ozone or bacterial challenge of the airway
(42). In two of these models, some restoration of normal
function was achieved by providing unpurified populations
of cells containing the cells typically found in that epithelial
site (30, 32); however, since the reconstituting populations
were heterogeneous, no conclusions could be reached re-
garding which    cell subset(s) were responsible for this
down-regulation. This study thus represents a novel dem-
onstration that a local functional impairment at an epithelial
interface can be attributed to the specific absence of the lo-
cal    cell subset constitutively resident within that tissue.
As such, the results provide evidence that IELs indeed can
exert local, nonredundant control of systemic inflammation
at the critical interface of the organism with its external en-
vironment. Such regulation of inflammation by locally res-
ident    cells may act in concert with recirculating    cells,
which also have been demonstrated to influence the devel-
Figure 6. Reconstitution withV 5  E17 fetal thy-
mocytes (DETC precursors), but not V 5  adult periph-
eral lymph node    cells, down-regulates both spontane-
ous and irritant dermatitis in FVB.  /  mice. (A) Baseline
ear thickness and (B) irritant ear swelling reactions 24 h af-
ter three weekly applications of TPA in groups of 10-wk-
old FVB mice (n   4–5 mice per group; data expressed as
mean   SE): unreconstituted FVB.  /   mice (positive
controls); normal FVB.   mice (negative controls);
FVB. –/– mice reconstituted as 1–3-d-old neonates with
either 8   104 flow cytometry-purified (98% pure) V 5 
fetal thymocytes from E17 FVB    donors, or 107 periph-
eral lymph node cells (determined by flow cytometry to
contain 1.5   106 V 5     cells) obtained from 8-wk-old
FVB.  /  donors. (C) Flow cytometric analyses of epider-
mal cell suspensions prepared from the ears of a representa-
tive from each of the above four groups of mice. Num-
bers in lower right-hand corners of the quadrants of the
contour plots indicate percentages of live cells within
those quadrants.864 V 5  DETC Down-Regulate Cutaneous Inflammation
opment of inflammation in different disease models (8–10).
Furthermore, when considered together with the capacity
of DETC to suppress the growth of carcinomas (23), this
study suggests that DETC may have a general capacity to
preserve epithelial integrity, whether from local epithelial
cell damage, or from the disruptive effects of systemic infil-
tration. An analogous function may be shown by other IEL
subsets, including those in the gut, where IELs have like-
wise been implicated both in the killing of transformed ep-
ithelial cells (24–26), and in the prevention of inflammatory
bowel disease (43).
This paper is consistent with several previous studies
which have reported that DETC can down-regulate partic-
ular cutaneous inflammatory responses (27–31). However,
the experimental designs used in each of those studies did
not permit the conclusion that the V 5  DETC normal
resident in murine epidermis can display a unique, nonre-
dundant, capacity to down-regulate the    T cell–depen-
dent components of both spontaneous and chemically in-
duced contact dermatitis. For example, Bigby et al. (28)
reported that the capacities of several strains of mice to ex-
press ACD reactions after sensitization and challenge was
related to the different ratios of Langerhans cells to Thy-1 
DETC in normal skin of those different strains; however,
the correlative nature of this study precluded definitive as-
signment of a down-regulatory role to V 5  DETC.
Likewise, Sullivan et al. (27), documented a diminished
capacity to be sensitized to the allergen DNFB in mice
previously injected with DNBS-conjugated Thy-1  DETC,
while similar down-regulation of ACD was not seen in re-
cipients of haptenated Langerhans cells or haptenated kera-
tinocytes. Nonetheless, this study also did not show that
such down-regulatory capacity was unique to DETC as
opposed to other subsets of    cells. Moreover, the lack of
evidence that prototypic V 5/V 1  DETC migrate from
the skin of adult mice to the draining lymph nodes or the
systemic circulation (12) raises some questions about the
biological relevance of this study as well as another (29) in
which the experimental design involved intravenous trans-
fer to normal adult recipients of a subset of    cells whose
distribution in adult mice is apparently restricted to the
skin.
Like this report, two previous studies have used   / 
mice to investigate the role of    cells in cutaneous inflam-
matory responses. A report showing that C57BL/6.  / 
mice displayed augmented ACD reactions to DNFB com-
pared with wild-type controls (31) appears a priori to con-
flict with our failure in this study to show consistent differ-
ences between C57BL/6.  /  and control mice in their
ACD responses to DNFB. However, while the studies re-
ported in the present study compared inbred   /  to inbred
control mice, the controls used by Weigmann et al. for
comparison to inbred C57BL/6.  /  mice were (129  
C57BL/6)F1 animals. Given the recognized differences in
the magnitude of ACD responses in different mouse strains
(28), it is possible that genetic disparity, rather than the pres-
ence or absence of    cells, was responsible for some or all
of the differences in ACD responses reported in that study.
Second, Shiohara and colleagues reported that C57BL/
6.  /  mice failed to down-regulate the intraepidermal
component of cutaneous graft-versus-host disease after re-
injection into the footpad of cloned, MHC class II autore-
active CD4     cells; in contrast, intraepidermal “resis-
tance” was seen in the footpads of C57BL/6.  /  mice
previously injected with unpurified fetal thymocytes from
control,    E14–16 fetal donors (30). The apparent con-
trast between this phenotype obtained for C57BL/6.  / 
mice and the lack of phenotype of C57BL/6.  /  mice
shown here regarding spontaneous or chemically induced
dermatitis, may reflect the very powerful proinflammatory
stimulus adopted by Shiohara and colleagues. This not-
withstanding, the two studies are highly consistent in at-
tributing immunoregulatory function to DETC. Neverthe-
less, the present studies substantially extend those of
Shiohara et al. by showing that among the various popula-
tions of cells present in the E14–17 fetal thymus, V 5 
DETC precursors are sufficient for down-regulating a vari-
ety of cutaneous inflammatory responses, including those
physiologic responses that occur spontaneously. By con-
trast, at least some other subpopulations of    cells, such as
those present in the PLNs, are unable to mediate such local
down-regulation, despite their ability to enter the skin in
substantial numbers.
The functional importance of DETC that is revealed in
this study provides a powerful complement to one previous
and two more recent molecular genetic studies suggesting
that the stable establishment of DETC repertoires in vivo
depends on the IELs expressing a particular type of TCR
(13, 44, 45). For example, in V 5 /  mice, congenitally un-
able to express the canonical V 5/V 1 DETC receptor, a
substantial fraction of the “substitute” DETC that develop
utilize a novel V 1/V 1 chain pairing to encode a TCR re-
active to a DETC-specific clonotypic antibody (13).
The spontaneous, localized, cutaneous inflammation
that develops in some, but not other strains of   /  mice
has several similarities to the dermatitis previously reported
to develop in the NC/Nga mouse (46–48), which has
been proposed as a relevant mouse model for human
atopic dermatitis, a common, chronic, and incompletely
understood inflammatory skin disease with a broad socio-
economic impact throughout the world (49). Shared fea-
tures of the animal model described in the present studies
with human atopic dermatitis include genetic predisposi-
tion (50–55); histopathology (56) dependence on    T
cells (57); localization to areas of skin also commonly ex-
posed to environmental irritants and/or allergens (58); and
increased expression of contact dermatitis (59). Additional
studies evaluating IgE levels and the effects of environ-
mental manipulation on the development of the dermati-
tis, as well as more detailed genetic analyses (see below)
will be required to clarify other similarities and/or differ-
ences between the present model, the NC/NGA model,
and human atopic dermatitis. To date, no evidence has
correlated human atopic dermatitis to either a numerical or
functional deficiency in    cells; furthermore, human skin
clearly is not obviously populated with a precise pheno-865 Girardi et al.
typic homologue of the V 5  DETC found in murine
skin (60). On the other hand, recent analysis of normal hu-
man skin has revealed that cutaneous    T cells demon-
strate a restricted TCR-   repertoire distinct from that of
peripheral blood    T cells (61), and it is conceivable that
such human cutaneous    cells represent functional equiv-
alents of murine intracutaneous V 5  regulatory cells. Im-
portantly, the work presented here focuses attention on
the potential for local resident cells to control the magni-
tude of tissue inflammation by systemic cells in a unique
and nonredundant fashion.
These studies have not definitively addressed several
longstanding questions in the arena of cutaneous    cell
immunobiology, including the relevant mechanism(s) by
which these cells exert their down-regulatory effects in the
skin. Do DETC down-regulate   -dependent inflamma-
tory responses via direct effects on such T cells or a subset
thereof (e.g., Th2 or Th1), or via indirect effects, for exam-
ple on the keratinocytes with which they are in intimate
contact, on other cells normally resident in the skin (e.g.,
mast cells), or on cells recruited into the skin in response to
inflammatory stimuli (e.g., monocyte/macrophages)? Like-
wise, do DETC down-regulate inflammation by elaborat-
ing antiinflammatory cytokines, by directly killing infiltrat-
ing cells, and/or by rendering the local tissue resistant to
inflammatory cells? One strategy to address these latter pos-
sibilities will be to compare chemical induced and/or spon-
taneous dermatitis in NOD.  /  and/or FVB.  /  mice
with similar mice reconstituted as newborns with V 5  fe-
tal thymocytes from donors genetically deficient in specific
molecules known or suspected to be produced by DETC
(e.g., IFN- , IL-10, TGF- , Fas-L, granzymes, perforin)
(20–22). Moreover, a recent large scale description of genes
expressed by murine gut IELs (62) has identified other can-
didate molecules that may be responsible for immunoregu-
lation by IELs, including DETC; such molecules include
prothymosin  4 (63) and monoclonal nonspecific suppres-
sor factor (64).
Finally, the results presented herein represent the first
demonstration of a strain-dependent, spontaneous pheno-
type developing in an antigen receptor knockout mouse.
Genetic differences between C57BL/6 mice and FVB or
NOD mice render the former strain phenotypically resis-
tant, and the latter strains phenotypically susceptible to the
increased cutaneous inflammation that results from    cell
(DETC) deficiency. Such resistance of C57BL/6.  /  mice
could mean that they lack the necessary cell(s) and/or fac-
tor(s) required to initiate and/or express spontaneous der-
matitis in the absence of    cells (while NOD and FVB
mice possess such cells/factors). Alternatively, C57BL/6
mice, but not either FVB or NOD mice, possess additional
cell(s)/factor(s) that can down-regulate the initiation and/
or expression of spontaneous inflammation in the absence
of    cells. The initial genetic analyses of such differences
presented in this study are consistent with a single autoso-
mal gene being primarily responsible for controlling such
resistance/susceptibility. Genome-wide microsatellite map-
ping studies are underway to determine the actual number
and identity of relevant modifier loci in NOD.  /  and
FVB.  /  mice. These studies should reveal whether the
loci controlling spontaneous dermatitis in susceptible   / 
mice are similar to any of the loci previously linked to sus-
ceptibility either to atopic dermatitis in humans (50–55)
and/or to the “atopic-like” dermatitis seen in other mouse
models (48, 65–68). Likewise, it will be useful to compare
the loci controlling spontaneous dermatitis in NOD.  / 
and FVB.  /  mice with those regulating susceptibility of
NOD mice to autoimmunity (69, 70). In conclusion, addi-
tional studies aimed at understanding the genetic, regula-
tory, and effector mechanisms which govern the actions of
a skin-specific subset of    cells in mice, are likely to pro-
vide insights into the complex local regulation of the wide
variety of inflammatory diseases which can affect the epi-
thelial interfaces (i.e., skin, respiratory, gastrointestinal, and
genitourinary tracts) of many species, including humans.
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